Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry, v3.4.2, was added to the study record history; a government-funding operating-status notice and the prior revision note v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding and current operating status was added, directing users to official status sources. The revision tag was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check29 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights (green for additions, red for deletions) with a new Revision: v3.4.0 tag. The previous Revision: v3.3.4 entry and the No FEAR Act data entry were removed.SummaryDifference1.0%

- Check43 days agoChange DetectedVersion v3.3.4 appears in the page history, replacing v3.3.3. This is a minor site revision and does not modify study data or user-facing content.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check93 days agoChange DetectedRecord history shows a new revision v3.3.2 was added and revision v3.2.0 was removed from the NCT02676869 record, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.